Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection

AIDS ◽  
2000 ◽  
Vol 14 (7) ◽  
pp. 845-852 ◽  
Author(s):  
Carl J. Fichtenbaum ◽  
Robert Zackin ◽  
Natasa Rajicic ◽  
William G. Powderly ◽  
L. Joseph Wheat ◽  
...  
2001 ◽  
Vol 58 (11) ◽  
pp. 1021-1024 ◽  
Author(s):  
Paul J. Dentinger ◽  
Chad F. Swenson ◽  
Nasr H. Anaizi

2015 ◽  
Vol 3 (3) ◽  
pp. 130-135
Author(s):  
Rakesh Basavareddy ◽  
Asha Basavareddy ◽  
Shimoga Laxman Ravi ◽  
Bilagumba Ramu Kiran ◽  
Gadwalkar R. Srikant

Abstract Background and Objectives: Tuberculosis (TB) and the human immunodeficiency virus (HIV) infection have reached epidemic proportions in our country. This study was undertaken to know the seroprevalence of HIV infection among TB patients and to evaluate the various clinical features of TB in seropositive and seronegative patients. This study was undertaken in Vijayanagara Institute of Medical Sciences, Bellary. It was cross-sectional comparative observational study conducted from December 2010 to May 2012. Materials and Methods: A total of 100 consecutive patients diagnosed with TB satisfying inclusion criteria were selected for the study. All patients went through a detailed evaluation along with testing for HIV seroprevalence. Chi-square and Student’s t-tests used to find the significance between two groups. Results: The overall HIV seroprevalence among TB patients was 8%. Seroprevalence was highest in the age group between 31 and 40 years at 29.41% (odds ratio [OR] = 11.11, P = 0.003). It was found that seropositive TB patients were more likely to present with significant weight loss (OR = 19.25, P= 0.000), and have lymphadenopathy OR = 13.24, P = 0.002) and oral candidiasis (OR = 49.44, P = 0.000) on examination. Bilateral chest radiographic involvement (OR = 57.40, P = 0.000) and the disseminated variety of the disease (OR = 29.67, P = 0.001) are also more probable. Conclusions: Human immunodeficiency virus seroprevalence is quite high among TB patients in Bellary. During the evaluation of TB patients, the possibility of HIV co-infection should be kept in mind, and thus adequate knowledge of the likely clinical features is absolutely necessary.


2018 ◽  
Vol 10 (2) ◽  
pp. 160-164
Author(s):  
Jessica Maribel Reinoso Herrera ◽  
María Eugenia Seminario Vintimilla ◽  
Juan Arias Deidán

BACKGROUND: Histoplasmosis is a frequent systemic mycosis in immunocompromised patients. The clinic is variable and is considered the most common respiratory mycosis worldwide, presenting a higher prevalence in tropical areas including South America. It is estimated that there are forty million patients, calculating two hundred thousand new cases annually. In Ecuador, the epidemiology of the disease is unknown, but it is estimated that 11.1% of patients with AIDS have histoplasmosis. CASE REPORT: Male patient of 23 years old, from Oro - Ecuador, with a history of AIDS diagnosed four years ago, with poor adherence to antiretroviral treatment and pulmonary tuberculosis, is admitted for presenting fever of two weeks evolution, asthenia, productive cough, weight loss, scaly erythematous-violaceous papules spread throughout the integument, with mucosal involvement. The risk factors presented by the patient for histoplasmosis were the lack of compliance with antiretroviral treatment and living in a rural area with exposure to poultry excrement. EVOLUTION: The patient was hospitalized with diagnosis of disseminated cutaneous histoplasmosis, AIDS, pulmonary tuberculosis, oral candidiasis and anal herpes. Antiretroviral, antituberculous treatment was continued and Amphotericin-B and itraconazole were started; later the patient was discharged with clinical improvement. CONCLUSION: Dermatoses play an important role in the early diagnosis of histoplasmosis. When there are comorbidities associated with the disease, such as AIDS and pulmonary tuberculosis. It is necessary to rethink the treatment, due to the drug interaction that may exist between Itraconazole and Rifampicin. The patient received Amphotericin-B until clinical improvement. For the prevention of opportunistic diseases, a correct adherence to the antiretroviral treatment, avoid the habitat of the fungus as bird or cave farms and before the risk of exposure, the adequate use of a mask.


1998 ◽  
Vol 129 (2) ◽  
pp. 187-194 ◽  
Author(s):  
LISA S. JACOB ◽  
CATHERINE M. FLAITZ ◽  
C. MARK NICHOLS ◽  
M. JOHN HICKS

1992 ◽  
Vol 24 (1) ◽  
pp. 35-39 ◽  
Author(s):  
John-Erik Stig Hansen ◽  
Claus Nielsen ◽  
Annette Svenningsen ◽  
Niels Witzke ◽  
Lars R. Mathiesen

1990 ◽  
Vol 69 (5) ◽  
pp. 591-596 ◽  
Author(s):  
Morten Schiødt ◽  
Poul B. Bakilana ◽  
John F.R. Hiza ◽  
John F. Shao ◽  
Ib Bygbjerg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document